Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Vsevolod V. Matveev"'
Autor:
Gwenaelle Gravis, Vsevolod V. Matveev, Tony Elliott, Camilla Thellenberg Karlsson, Laurence L. Hatteville, Francisco F. Orlandi, Thierry Gil, A. Birtle, Ian F. Tannock, Luciano L. Viana, Iwona Skoneczna, Sergey Ivanov, Aude Flechon, Emmanuelle E. Magherini, Bertrand Tombal, Osvaldo O. Arén, Karim Fizazi, Sevil S. Bavbek, Daniel D. Petrylak, M. Rosenthal, Oleg Karyakin
Publikováno v:
The Lancet Oncology. 14:760-768
Summary Background Docetaxel plus prednisone is standard first-line chemotherapy for men with metastatic castrate-resistant prostate cancer. Aflibercept is a recombinant human fusion protein that binds A and B isoforms of VEGF and placental growth fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::014dc669c0c996c406632b5a837d6538
https://doi.org/10.1016/s1470-2045(13)70184-0
https://doi.org/10.1016/s1470-2045(13)70184-0
Autor:
Matveev V; N. N. Blokhin Russian Cancer Research Center, Moscow, Russia., Gao X; Department of Urology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Kopyltsov E; Budgetary Healthcare Institution of Omsk Region, Clinical Oncological Dispensary, Omsk, Russia., Luo J; Department of Urology, First Affiliated Hospital of Zhejiang University, Hangzhou, China., Wei Q; Department of Urology, West China Hospital of Sichuan University, Chengdu, China., Ye D; Department of Urology, Fudan University Cancer Hospital, Shanghai, China., Zhou F; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China., Cabri P; Department of Urology, Ipsen, Boulogne-Billancourt, France., Houchard A; Department of Urology, Ipsen, Boulogne-Billancourt, France., Mahmood A; Department of Urology, Ipsen, Boulogne-Billancourt, France., Xie LP; Department of Urology, First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Publikováno v:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2024 Dec; Vol. 20 (6), pp. 738-746. Date of Electronic Publication: 2024 Jul 03.
Autor:
Chahine SY; University of Washington School of Medicine, Seattle, WA, USA. Electronic address: sophic2@uw.edu., Alkhatib KY; Department of Urology, University of Pennsylvania, Philadelphia, PA, USA., Arakelyan G; N.N. Blokhin Russian Cancer Center, Moscow, Russia., Buxton C; University of Washington School of Medicine, Seattle, WA, USA., Giannarini G; Santa Maria della Misericordia University Hospital, Udine, Italy., Hamilton RJ; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada., Holt SK; Department of Urology, University of Washington, Seattle, WA, USA., Bernhard JC; Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Jiang DM; Princess Margaret Cancer Centre, Toronto, Canada., Lin D; Department of Urology, University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA., Liu JJ; Oregon Health & Science University, Portland, OR, USA., Manley B; Moffitt Cancer Center, Tampa, FL, USA., Master VA; Emory School of Medicine, Atlanta, GA, USA; Winship Cancer Institute, Atlanta, GA, USA., Matveev V; N.N. Blokhin Russian Cancer Center, Moscow, Russia., Necchi A; Vita-Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Hospital, Milan, Italy., Packiam VT; Department of Urology, University of Iowa, Iowa City, IA, USA., Patel SH; Brady Urological Institute, Johns Hopkins, Baltimore, MD, USA., Peak T; Moffitt Cancer Center, Tampa, FL, USA., Peyton CC; Department of Urology, University of Alabama at Birmingham, Birmingham, AL, USA., Pierorazio PM; Department of Urology, University of Pennsylvania, Philadelphia, PA, USA., Prakash G; Department of Urologic Oncology, Tate Memorial Centre, Mumbai, India., Salari K; Massachusetts General Hospital, Boston, MA, USA; Department of Urology, Harvard Medical School, Boston, MA, USA., Sexton WJ; Moffitt Cancer Center, Tampa, FL, USA., Singla N; Brady Urological Institute, Johns Hopkins, Baltimore, MD, USA., Spiess PE; Moffitt Cancer Center, Tampa, FL, USA., Psutka SP; Department of Urology, University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA.
Publikováno v:
European urology focus [Eur Urol Focus] 2024 Aug 14. Date of Electronic Publication: 2024 Aug 14.
Autor:
Senkin S; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Moody S; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK., Díaz-Gay M; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Abedi-Ardekani B; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Cattiaux T; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Ferreiro-Iglesias A; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Wang J; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK., Fitzgerald S; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK., Kazachkova M; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.; Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA, USA., Vangara R; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Le AP; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK., Bergstrom EN; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Khandekar A; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Otlu B; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.; Department of Health Informatics, Graduate School of Informatics, Middle East Technical University, Ankara, Turkey., Cheema S; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK., Latimer C; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK., Thomas E; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK., Atkins JR; Cancer Epidemiology Unit, The Nuffield Department of Population Health, University of Oxford, Oxford, UK., Smith-Byrne K; Cancer Epidemiology Unit, The Nuffield Department of Population Health, University of Oxford, Oxford, UK., Cortez Cardoso Penha R; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Carreira C; Evidence Synthesis and Classification Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Chopard P; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Gaborieau V; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Keski-Rahkonen P; Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Jones D; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK., Teague JW; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK., Ferlicot S; Service d'Anatomie Pathologique, Assistance Publique-Hôpitaux de Paris, Univeristé Paris-Saclay, Le Kremlin-Bicêtre, France., Asgari M; Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.; Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran., Sangkhathat S; Translational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand., Attawettayanon W; Division of Urology, Department of Surgery, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand., Świątkowska B; Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Łódź, Poland., Jarmalaite S; Laboratory of Genetic Diagnostic, National Cancer Institute, Vilnius, Lithuania.; Department of Botany and Genetics, Institute of Biosciences, Vilnius University, Vilnius, Lithuania., Sabaliauskaite R; Laboratory of Genetic Diagnostic, National Cancer Institute, Vilnius, Lithuania., Shibata T; Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Minato-ku, Japan.; Division of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Japan., Fukagawa A; Division of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Japan.; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan., Mates D; Occupational Health and Toxicology Department, National Center for Environmental Risk Monitoring, National Institute of Public Health, Bucharest, Romania., Jinga V; Urology Department, Carol Davila University of Medicine and Pharmacy, Prof. Dr. Th. Burghele Clinical Hospital, Bucharest, Romania., Rascu S; Urology Department, Carol Davila University of Medicine and Pharmacy, Prof. Dr. Th. Burghele Clinical Hospital, Bucharest, Romania., Mijuskovic M; Clinic of Nephrology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia., Savic S; Department of Urology, University Hospital Dr D. Misovic Clinical Center, Belgrade, Serbia., Milosavljevic S; International Organization for Cancer Prevention and Research, Belgrade, Serbia., Bartlett JMS; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Albert M; Centre for Biodiversity Genomics, University of Guelph, Guelph, Ontario, Canada.; Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Phouthavongsy L; Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Ashton-Prolla P; Experimental Research Center, Genomic Medicine Laboratory, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Post-Graduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Botton MR; Transplant Immunology and Personalized Medicine Unit, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Silva Neto B; Service of Urology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Post-Graduate Program in Medicine: Surgical Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Bezerra SM; Department of Anatomic Pathology, A. C. Camargo Cancer Center, São Paulo, Brazil., Curado MP; Department of Epidemiology, A. C. Camargo Cancer Center, São Paulo, Brazil., Zequi SC; Department of Urology, A. C. Camargo Cancer Center, São Paulo, Brazil.; National Institute for Science and Technology in Oncogenomics and Therapeutic Innovation, A.C. Camargo Cancer Center, São Paulo, Brazil.; Latin American Renal Cancer Group (LARCG), São Paulo, Brazil.; Department of Surgery, Division of Urology, Sao Paulo Federal University (UNIFESP), São Paulo, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.; Life and Health Sciences Research Institute (ICVS), School of Medicine, Minho University, Braga, Portugal., Faria EF; Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil.; Department of Urology, Barretos Cancer Hospital, Barretos, Brazil., de Menezes NS; Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil., Ferrari RS; Department of Urology, Barretos Cancer Hospital, Barretos, Brazil., Banks RE; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Vasudev NS; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Zaridze D; Department of Clinical Epidemiology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia., Mukeriya A; Department of Clinical Epidemiology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia., Shangina O; Department of Clinical Epidemiology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia., Matveev V; Department of Urology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia., Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Navratilova M; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Holcatova I; Institute of Public Health and Preventive Medicine, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.; Department of Oncology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic., Hornakova A; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic., Janout V; Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic., Purdue MP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Rothman N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Ueland PM; Bevital AS, Bergen, Norway., Johansson M; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., McKay J; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Scelo G; Observational and Pragmatic Research Institute Pte Ltd, Singapore, Singapore., Chanudet E; Department of Pathology, Radboud University Medical Centre, Nijmegen, Netherlands., Humphreys L; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK., de Carvalho AC; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Perdomo S; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Alexandrov LB; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Stratton MR; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK., Brennan P; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France. brennanp@iarc.who.int.
Publikováno v:
Nature [Nature] 2024 May; Vol. 629 (8013), pp. 910-918. Date of Electronic Publication: 2024 May 01.
Autor:
Mink JN; Department of Urology and Paediatric Urology, Saarland University, 66421 Homburg, Germany., Khalmurzaev O; Department of Urology and Paediatric Urology, Saarland University, 66421 Homburg, Germany.; Department of Urology, Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology', Ministry of Health of the Russian Federation, Moscow 115478, Russia., Pryalukhin A; Institute of Pathology, Saarland University Medical Centre, 66421 Homburg, Germany., Geppert CI; Institute of Pathology, University Erlangen-Nuremberg, 91054 Erlangen, Germany., Lohse S; Institute of Virology, Saarland University, 66123 Homburg, Germany., Bende K; Institute of Pathology, University Erlangen-Nuremberg, 91054 Erlangen, Germany., Lobo J; Department of Pathology and Cancer Biology and Epigenetics Group-Research Center, Portuguese Oncology Institute of Porto/Porto Comprehensive Cancer Center Raquel Seruca, School of Medicine and Biomedical Sciences (ICBAS), University of Porto, 4050-513 Porto, Portugal., Henrique R; Department of Pathology and Cancer Biology and Epigenetics Group-Research Center, Portuguese Oncology Institute of Porto/Porto Comprehensive Cancer Center Raquel Seruca, School of Medicine and Biomedical Sciences (ICBAS), University of Porto, 4050-513 Porto, Portugal., Loertzer H; Clinic of Urology and Paediatric Urology, Westpfalz-Klinikum, 67655 Kaiserslautern, Germany., Steffens J; Department of Urology and Paediatric Urology, St. Antonius Hospital, 52249 Eschweiler, Germany., Jerónimo C; Department of Pathology and Cancer Biology and Epigenetics Group-Research Center, Portuguese Oncology Institute of Porto/Porto Comprehensive Cancer Center Raquel Seruca, School of Medicine and Biomedical Sciences (ICBAS), University of Porto, 4050-513 Porto, Portugal., Wunderlich H; Clinic of Urology and Paediatric Urology, St. Georg Klinikum, 99817 Eisenach, Germany., Heinzelbecker J; Department of Urology and Paediatric Urology, Saarland University, 66421 Homburg, Germany., Bohle RM; Institute of Pathology, Saarland University Medical Centre, 66421 Homburg, Germany., Stöckle M; Department of Urology and Paediatric Urology, Saarland University, 66421 Homburg, Germany., Matveev V; Department of Urology, Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology', Ministry of Health of the Russian Federation, Moscow 115478, Russia., Hartmann A; Institute of Pathology, University Erlangen-Nuremberg, 91054 Erlangen, Germany., Junker K; Department of Urology and Paediatric Urology, Saarland University, 66421 Homburg, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Sep 27; Vol. 15 (19). Date of Electronic Publication: 2023 Sep 27.
Autor:
Mink JN; Klinik für Urologie und Kinderurologie, Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes, Homburg, Deutschland., Khalmurzaev O; Klinik für Urologie und Kinderurologie, Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes, Homburg, Deutschland.; Abteilung für Urologie, N N Blokhin NMRCO, Moskva, Russian Federation., Pryalukhin A; Abteilung für Pathologie, Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes, Homburg, Deutschland.; Institut für Pathologie, Universitätsklinikum Bonn, Bonn, Deutschland., Hölters S; Klinik für Urologie und Kinderurologie, Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes, Homburg, Deutschland., Geppert C; Institut für Pathologie, Universitätsklinikum Erlangen, Erlangen, Deutschland., Lohse S; Abteilung für Virologie, Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes, Homburg, Deutschland., Bende K; Institut für Pathologie, Universitätsklinikum Erlangen, Erlangen, Deutschland., Lobo J; Abteilung für Pathologie, IPO-PORTO, Porto, Portugal., Henrique R; Abteilung für Pathologie, IPO-PORTO, Porto, Portugal., Loertzer H; Abteilung für Urologie und Kinderurologie, Westpfalz Klinikum Gmbh, Kaiserslautern, Deutschland., Steffens J; Klinik für Urologie und Kinderurologie, St-Antonius-Hospital gGmbH, Eschweiler, Deutschland., Jerónimo C; Abteilung für Pathologie, IPO-PORTO, Porto, Portugal.; Portuguese Oncology Institute of Porto, Research Center (CI-IPOP), Porto., Wunderlich H; Abteilung für Urologie und Kinderurologie, St. Georg Klinikum Eisenach, Eisenach, Deutschland., Heinzelbecker J; Klinik für Urologie und Kinderurologie, Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes, Homburg, Deutschland., Bohle R; Abteilung für Pathologie, Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes, Homburg, Deutschland., Stöckle M; Klinik für Urologie und Kinderurologie, Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes, Homburg, Deutschland., Matveev V; Abteilung für Urologie, N N Blokhin NMRCO, Moskva, Russian Federation., Hartmann A; Institut für Pathologie, Universitätsklinikum Erlangen, Erlangen, Deutschland., Junker K; Klinik für Urologie und Kinderurologie, Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes, Homburg, Deutschland.
Publikováno v:
Aktuelle Urologie [Aktuelle Urol] 2023 Aug; Vol. 54 (4), pp. 274-284. Date of Electronic Publication: 2023 Aug 04.
Autor:
Sheikh M; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Mukeriya A; Department of Epidemiology, N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia., Zahed H; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Feng X; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Robbins HA; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Shangina O; Department of Epidemiology, N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia., Matveev V; Department of Urology, N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia., Brennan P; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Zaridze D; Department of Epidemiology, N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 May 20; Vol. 41 (15), pp. 2747-2755. Date of Electronic Publication: 2023 Mar 29.
Autor:
Apanovich N; Laboratory of Molecular Genetics of Complex Inherited Diseases, Research Centre for Medical Genetics, Moscow, Russia., Apanovich P; Laboratory of Molecular Genetics of Complex Inherited Diseases, Research Centre for Medical Genetics, Moscow, Russia., Mansorunov D; Laboratory of Molecular Genetics of Complex Inherited Diseases, Research Centre for Medical Genetics, Moscow, Russia., Kuzevanova A; Laboratory of Molecular Genetics of Complex Inherited Diseases, Research Centre for Medical Genetics, Moscow, Russia., Matveev V; Department of Oncourology, Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow, Russia., Karpukhin A; Laboratory of Molecular Genetics of Complex Inherited Diseases, Research Centre for Medical Genetics, Moscow, Russia.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 May 11; Vol. 11, pp. 615787. Date of Electronic Publication: 2021 May 11 (Print Publication: 2021).
Autor:
Bjartell A; Department of Urology, Skåne University Hospital Malmö, Jan Waldenströms gata 5, SE 205 02, Malmö, Sweden. anders.bjartell@med.lu.se.; Department of Translational Medicine, Medical Faculty, Lund University, Malmö, Sweden. anders.bjartell@med.lu.se., Lumen N; Department of Urology, Ghent University Hospital, Ghent, Belgium., Maroto P; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain., Paiss T; Urologie team Ulm, Ulm, Germany., Gomez-Veiga F; Urology Department and Kidney Transplant Unit, Translational Research Group of Urology GITUR-IBSAL, Salamanca University Hospital, Salamanca, Spain., Birtle A; Royal Preston Hospital, Preston, UK., Kramer G; Department of Urology, Medical University of Vienna, Vienna, Austria., Kalinka E; Clinic of Oncology, Polish Mother's Memorial Hospital, Research Institute, Lodz, Poland., Spaëth D; Centre d'Oncologie de Gentilly, Nancy, France., Feyerabend S; Studienpraxis Urologie, Nürtingen, Germany., Matveev V; N.N. Blokhin National Cancer Research Center, Moscow, Russia., Lefresne F; EMEA Oncology, Janssen Pharmaceutica N.V., Beerse, Belgium., Lukac M; Parexel International Czech Republic s.r.o, on behalf of Janssen Pharmaceutica N.V., Beerse, Belgium., Wapenaar R; Janssen-Cilag B.V., Breda, The Netherlands., Costa L; Oncology Division, Faculdade de Medicina, Hospital de Santa Maria, Instituto de Medicina Molecular, Universidade de Lisboa, Lisbon, Portugal., Chowdhury S; Guy's and St Thomas' NHS Foundation Trust and Sarah Cannon Research Institute, London, UK.
Publikováno v:
Targeted oncology [Target Oncol] 2021 May; Vol. 16 (3), pp. 357-367. Date of Electronic Publication: 2021 Apr 07.
Autor:
Volkova M; N.N. Blokhin National Medical Research Center for Oncology Moscow, Russian Federation., Tsimafeyeu I; Institute of Oncology, Hadassah Moscow Moscow, Russian Federation.; Kidney Cancer Research Bureau Moscow, Russian Federation., Olshanskaya A; N.N. Blokhin National Medical Research Center for Oncology Moscow, Russian Federation., Khochenkova Y; N.N. Blokhin National Medical Research Center for Oncology Moscow, Russian Federation., Solomko E; N.N. Blokhin National Medical Research Center for Oncology Moscow, Russian Federation., Ashuba S; N.N. Blokhin National Medical Research Center for Oncology Moscow, Russian Federation., Matveev V; N.N. Blokhin National Medical Research Center for Oncology Moscow, Russian Federation., Khochenkov D; N.N. Blokhin National Medical Research Center for Oncology Moscow, Russian Federation.; Togliatti State University Togliatti, Russian Federation.
Publikováno v:
American journal of clinical and experimental urology [Am J Clin Exp Urol] 2021 Feb 15; Vol. 9 (1), pp. 65-72. Date of Electronic Publication: 2021 Feb 15 (Print Publication: 2021).